---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-273633"
form_type: "8-K"
ticker: "FATE"
cik: "0001434316"
company_name: "FATE THERAPEUTICS INC"
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T09:07:21.777214+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Fate Therapeutics files $300M shelf, enters $100M ATM with Jefferies; terminates prior agreement

## Summary
- Filed S-3 shelf registration for up to $300M of common, preferred, debt, warrants, and units.
- Entered ATM offering agreement with Jefferies for up to $100M of common stock at market prices.
- Jefferies will receive a 3% commission on gross proceeds from any ATM sales.
- Prior ATM facility dated Nov 4, 2021 terminated and replaced by the new agreement.

## SEC filing metadata
- accession: 0001193125-23-273633
- form_type: 8-K
- ticker: FATE
- cik: 0001434316
- company_name: FATE THERAPEUTICS INC
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434316/000119312523273633/0001193125-23-273633-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434316/000119312523273633/d554381d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-273633
- JSON: https://secwatch.observer/filing/0001193125-23-273633.json
- Plain text: https://secwatch.observer/filing/0001193125-23-273633.txt

## Key facts
- Material Agreements
  FATE THERAPEUTICS INC entered into Open Market Sale Agreement with Jefferies LLC valued at up to $100,000,000 (effective 2023-11-08).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Jefferies LLC
  - Value: up to $100,000,000
  - Effective: 2023-11-08
  source text: on November 8, 2023, the Company entered into an Open Market Sale Agreement SM (the “Agreement”) with Jefferies LLC (“Jefferies”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its Common Stock having an aggregate offering price of up to $100,000,000 (the “Placement Shares”), through Jefferies as its sales agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434316/000119312523273633/0001193125-23-273633-index.htm
- Material Agreements
  FATE THERAPEUTICS INC terminated Open Market Sale Agreement with Jefferies LLC (effective 2023-11-08).
  - Action: termination
  - Agreement: atm program
  - Counterparty: Jefferies LLC
  - Effective: 2023-11-08
  source text: Effective upon the execution of the Agreement, the Open Market Sale Agreement SM , dated November 4, 2021, by and between the Company and Jefferies (the “Prior Agreement”), was terminated and superseded by the Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434316/000119312523273633/0001193125-23-273633-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.